202 related articles for article (PubMed ID: 7004344)
1. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
Markowitz SM; Sibilla DJ
Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
3. [In vitro study of combinations between third-generation cephalosporins and aminoglycosides on Enterobacteriaceae].
Fosse T; Soussy CJ; Duval J
Pathol Biol (Paris); 1983 Jun; 31(6):483-7. PubMed ID: 6348654
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Meyer RD; Pasiecznik K
Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
[TBL] [Abstract][Full Text] [Related]
5. Netilmicin: in-vitro activity compared with that of other aminoglycosides against Serratia marcescens.
Langstaff D; Schueler S; Righter J
J Antimicrob Chemother; 1983 Feb; 11(2):187-9. PubMed ID: 6339461
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
Kawakami Y; Okimura Y; Horiuchi N; Kanai M
Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
[No Abstract] [Full Text] [Related]
7. In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
Miller MA; Yousuf M; Griffin PS; Bartlett M; Crane JK
Microbiol Immunol; 1979; 23(10):955-64. PubMed ID: 390321
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.
Pogwizd SM; Lerner SA
Antimicrob Agents Chemother; 1976 Dec; 10(6):878-84. PubMed ID: 795373
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.
Kurtz TO; Winston DJ; Bruckner DA; Martin WJ
Antimicrob Agents Chemother; 1981 Aug; 20(2):239-43. PubMed ID: 6792982
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of clinical isolates of Serratia marcescens.
Alvarez JS; Regueiro B; Garrido MJ
Antimicrob Agents Chemother; 1979 Oct; 16(4):523-4. PubMed ID: 391150
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
Maslow MJ; Simberkoff MS; Rahal JJ
J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
[TBL] [Abstract][Full Text] [Related]
12. The comparative synergistic activity of amikacin, gentamicin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin against Serratia marcescens.
Fu KP; Neu HC
J Antibiot (Tokyo); 1978 Feb; 31(2):135-40. PubMed ID: 344298
[TBL] [Abstract][Full Text] [Related]
13. [In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
Sirot J; Sirot D; Garnier R; Joly B; Cluzel R
Pathol Biol (Paris); 1983 Jun; 31(6):480-2. PubMed ID: 6308542
[TBL] [Abstract][Full Text] [Related]
14. A laboratory assessment of the activities of four aminoglycosides.
Schrire L; Robinson RG; Koornhof HJ
S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
[TBL] [Abstract][Full Text] [Related]
15. Nonspecific aminoglycoside cross-resistance of Serratia marcescens.
Traub WH; Fukushima PI
Chemotherapy; 1979; 25(4):204-13. PubMed ID: 378576
[TBL] [Abstract][Full Text] [Related]
16. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
Murray PR
Antimicrob Agents Chemother; 1980 Mar; 17(3):474-6. PubMed ID: 6252830
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides.
Stephens M; Potten M; Bint AJ
Infection; 1979; 7(3):109-12. PubMed ID: 478651
[TBL] [Abstract][Full Text] [Related]
18. In-vitro susceptibility of clinical isolates of Serratia species to antimicrobial agents.
Sofianou D; Proya E; Kondodimou A
J Chemother; 1990 Apr; 2(2):79-81. PubMed ID: 2362189
[TBL] [Abstract][Full Text] [Related]
19. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
Husson MO; Izard D; Leclerc H
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
[TBL] [Abstract][Full Text] [Related]
20. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
